Antimicrobial Drug News and Research

RSS

Antimicrobials are substance that kills microorganisms such as bacteria or mold, or stops them from growing and causing disease.

Patients with chronic rhinosinusitis do not necessarily develop resistance to antibiotics

Patients with chronic rhinosinusitis (CRS, inflammation of the nasal passages and sinuses) do not necessarily develop resistance to antibiotics although they may be treated for long periods of time with these drugs

18 Oct 2004

MRSA bugs immunity to hospital disinfectants and antiseptics

Dangerous multi-drug-resistant bacteria are also developing immunity to hospital disinfectants and antiseptics, according to new research presented today at the Society for General Microbiology’s 155th Meeting at Trinity College Dublin.

8 Sep 2004

Stopping bacteria from talking to each other could help prevent serious infections

Stopping bacteria from talking to each other could help prevent serious infections say scientists from Aberdeen, in new research presented Monday at the Society for General Microbiology’s 155th Meeting at Trinity College Dublin.

7 Sep 2004

Toxic chemical in hand soaps, cleaner is deposited and remains in the environment long after the products are used

A toxic chemical used in hand soaps, cleaners and other personal care products to kill germs is deposited and remains in the environment long after the products are used, according to researchers at the Johns Hopkins Bloomberg School of Public Health.

18 Aug 2004

Research unlocks the mystery of the miraculous healing powers of honey

A Sydney researcher has unlocked the mystery of the miraculous healing powers of honey, adding to the calls for its use as a first line defence against serious infection.

11 Aug 2004

Yeast and tea tree oil kill MRSA superbug

Manchester Metropolitan University is working with a cutting edge technology firm to find a treatment for the hospital superbug MRSA which kills 5,000 patients each year.

23 Jul 2004

World's first personal facemask for SARS protection

Triosyn Corp., a developer of products aimed at protecting against microbial threats, announced today that tests conducted by Health Canada’s National Microbiology Laboratory show that Triosyn T-1000™ Series Respirators protect against Severe Acute Respiratory Syndrome (SARS).

21 Jul 2004

MRSA contamination can be reduced by using copper alloys for surfaces in healthcare facilities

Methicillin resistant Staphylococcus aureus (MRSA) is a virulent organism, essentially resistant to all beta-lactam antibiotics (for example: penicillins, ampicillins, cephalosporins). It can cause skin, bone and life-threatening blood infections, as well as pneumonia.

7 Jul 2004

Protein research may help develop new antibiotics

New findings about a protein that keeps cells alive by opening and closing pores within a cell's membrane may open the door to the development of new antibiotics.

30 Jun 2004

The EU is contributing €9 million to the “Vigilance against Viral Resistance” (VIRGIL) project

Viruses’ growing resistance to drugs means diseases such as hepatitis B and C are increasingly difficult to treat. New pandemics may arise with unforeseeable consequences.

29 Jun 2004

A viral respiratory infection common in children increases the risk of developing asthma

The study, published in The Journal of Infectious Diseases, is the first to show a link between respiratory syncytial virus, or RSV, infection and asthma in mice. A related study, also in mice, suggests that a medication neutralizing the virus could decrease children's chances of developing asthma.

28 Jun 2004

Drinking only bottled water associated with a two-fold risk of infection

Doing laundry using hot water and bleach may prevent infections in the home, while drinking only bottled water may promote infections, according to research.

2 Jun 2004

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Results from an ongoing surveillance study, PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology of the Ketolide Telithromycin – United States) Year 2 (2001-2002), suggest that KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates, including those resistant to other antimicrobial agents.

24 May 2004

Zinc may help to accelerate recovery from pneumonia

The addition of zinc to standard antimicrobial treatment may accelerate recovery from pneumonia, say researchers in this week's issue of The Lancet.

20 May 2004

Preventing antimicrobial resistance among long-term care residents

The Centers for Disease Control and Prevention (CDC) is spotlighting an educational campaign to help long-term care medical directors and clinicians prevent antimicrobial resistance and protect the health of their residents.

20 Apr 2004

Link between iron regulation and the immune system

Patients with chronic inflammatory disorders, including infections, inflammatory bowel disease, arthritis and cancer, commonly become anemic. The anemia can make them sicker, is sometimes severe enough to require a blood transfusion, and responds only partially to current treatments.